not tagged
not tagged
['biomarker', 'marker ']
also took the podium to present proffered paper. we saw few drugs approved after single-arm trials met criteria for substantial benefit by esmo-mcbs, however many drugs showed meaningful benefits suggesting benefit of biomarker based therapies may be underestimated by esmo-mcbs. 
New faculty at University of California, Irvine in Melanoma and Sarcoma with interest in phase 1. Former phase 1 fellow at MD Anderson. Ed Fel JCO Prec Onc.